Fatty liver associated with metabolic dysfunction caused by the consumption of a high-sucrose diet in rats: role of the gut-liver axis

Authors

  • Morena Wiszniewski University of Buenos Aires (UBA)/ National Council for Scientific and Technical Research (CONICET), City of Buenos Aires, Argentina
  • Malena Gromez National Council for Scientific and Technical Research (CONICET), City of Buenos Aires, Argentina
  • Antonella Pezanitti University of Buenos Aires (UBA), National Council for Scientific and Technical Research (CONICET), City of Buenos Aires, Argentina
  • Diego Mori University of Buenos Aires (UBA) / National Council for Scientific and Technical Research (CONICET), City of Buenos Aires, Argentina
  • Lilian Caldareri University of Buenos Aires (UBA) / National Council for Scientific and Technical Research (CONICET), City of Buenos Aires, Argentina
  • Federico Jara Universidad de Buenos Aires (UBA)/ Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Ciudad Autónoma de Buenos Aires, Argentina
  • Camila Martínez Calejman University of Buenos Aires (UBA) /National Council for Scientific and Technical Research (CONICET), City of Buenos Aires, Argentina
  • Cora Beatriz Cymeryng University of Buenos Aires (UBA)/ National Council for Scientific and Technical Research (CONICET), City of Buenos Aires, Argentina
  • Esteban Martin Repetto University of Buenos Aires (UBA)/ National Council for Scientific and Technical Research (CONICET), City of Buenos Aires, Argentina

DOI:

https://doi.org/10.47196/diab.v59i2Sup.1259

Keywords:

fatty liver, metabolic dysfunction, diet

Abstract

Introduction: over the past few years excessive carbohydrate consumption has been shown to alter gut microbiota and affect epithelial permeability, thus facilitating the passage of endotoxins into the circulation, promptly reaching the liver. 

Objectives: the goal of this study was to evaluate the intestinal and hepatic effects of a sucrose-rich diet (SRD) in Wistar rats and the effects of reverting to a standard diet.

Materials and methods: animals were assigned to control (C, n=8) and SRD (30% sucrose in water, n=8) groups, and the treatments were carried out for 12 weeks. In a second protocol, after 10 weeks on the SRD, a subgroup was returned to a standard diet for the last 2 weeks (SRD reversal, n=6).

Results: histological analysis of the ileum of the animals in the DRS group showed no epithelial alterations or changes in goblet cell content (H&E and Alcian Blue staining). However, a significant reduction in the expression of binding proteins was observed: ZO-1 and occludin (by qPCR), and claudin-1 (by immunofluorescence). In addition, a higher amount of bacterial DNA was detected in the liver and blood, and an increased ratio of Firmicutes/Bacteroidetes DNA (an indicator of dysbiosis) was detected in the feces, along with a significant decrease in the content of short-chain fatty acids (butyrate and acetate). Animals in the DRS group presented steatohepatitis (NAS score), characterized by increased parameters of inflammation, oxidative stress, endoplasmic reticulum stress, and apoptosis. Metabolically, there was a decrease in tissue sensitivity to insulin, which was associated with a more gluconeogenic and lipogenic profile without changes in lipid oxidation. 

Conclusions: reversion to a standard diet (DRS rev) did not induce histological changes in the liver, although it attenuated inflammation, ER stress, and apoptosis. This caloric restriction protocol also improved hepatic insulin sensitivity (via AKT) and promoted a more oxidative lipid profile, reducing circulating triglyceride levels, increased in the DRS group.

In summary, DRS administration induces intestinal dysbiosis and increased epithelial permeability and bacterial translocation, which could promote hepatic inflammatory processes and aggravate insulin resistance. Reverting to a standard diet improves hepatic metabolic parameters, although the possible association of these findings with the intestinal changes observed in the animals in the DRS group remains to be evaluated.

Author Biographies

Morena Wiszniewski, University of Buenos Aires (UBA)/ National Council for Scientific and Technical Research (CONICET), City of Buenos Aires, Argentina

Center for Pharmacological and Botanical Studies (CEFYBO) - Molecular Endocrinology Laboratory (LEM)

Malena Gromez, National Council for Scientific and Technical Research (CONICET), City of Buenos Aires, Argentina

Center for Pharmacological and Botanical Studies (CEFYBO) - Molecular Endocrinology Laboratory (LEM)

Antonella Pezanitti, University of Buenos Aires (UBA), National Council for Scientific and Technical Research (CONICET), City of Buenos Aires, Argentina

Center for Pharmacological and Botanical Studies (CEFYBO) - Molecular Endocrinology Laboratory (LEM)

Diego Mori, University of Buenos Aires (UBA) / National Council for Scientific and Technical Research (CONICET), City of Buenos Aires, Argentina

Center for Pharmacological and Botanical Studies (CEFYBO) - Molecular Endocrinology Laboratory (LEM)

Lilian Caldareri, University of Buenos Aires (UBA) / National Council for Scientific and Technical Research (CONICET), City of Buenos Aires, Argentina

Center for Pharmacological and Botanical Studies (CEFYBO) - Molecular Endocrinology Laboratory (LEM)

Federico Jara, Universidad de Buenos Aires (UBA)/ Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Ciudad Autónoma de Buenos Aires, Argentina

Center for Pharmacological and Botanical Studies (CEFYBO) - Molecular Endocrinology Laboratory (LEM)

Camila Martínez Calejman, University of Buenos Aires (UBA) /National Council for Scientific and Technical Research (CONICET), City of Buenos Aires, Argentina

Center for Pharmacological and Botanical Studies (CEFYBO) - Molecular Endocrinology Laboratory (LEM)

Cora Beatriz Cymeryng, University of Buenos Aires (UBA)/ National Council for Scientific and Technical Research (CONICET), City of Buenos Aires, Argentina

Center for Pharmacological and Botanical Studies (CEFYBO) - Molecular Endocrinology Laboratory (LEM)

Esteban Martin Repetto, University of Buenos Aires (UBA)/ National Council for Scientific and Technical Research (CONICET), City of Buenos Aires, Argentina

Center for Pharmacological and Botanical Studies (CEFYBO) - Molecular Endocrinology Laboratory (LEM)

References

-

Published

2025-07-30

Issue

Section

Annex: Subsidies 2023